Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors.
Wei MuEvangelia KatsoulakisChristopher J WhelanKenneth L GageMatthew B SchabathRobert James GilliesPublished in: British journal of cancer (2021)
PET/CT radiomics analysis has the potential to predict the probability of developing cachexia before the start of ICI, triggering aggressive monitoring to improve potential to achieve more clinical benefit.